Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2023-05-18 00:00:00 ET · period of report 2023-05-16 · accession 0000899243-23-013289 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-18 | 2023-05-16 | AMLX | FRATES JAMES M | CFO | M - OptEx | $6.88 | +32.5K | 88.2K | +58% | +$223.6K |
| DM | 2023-05-18 | 2023-05-16 | AMLX | FRATES JAMES M | CFO | S - Sale+OE | $26.94 | -32.5K | 55.7K | -37% | -$875.6K |
| D | 2023-05-18 | 2023-05-16 | AMLX | FRATES JAMES M | CFO | M - OptEx | $0.00 | -32.5K | 382.0K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-16 | M | A | 32,500 | $6.88 | 88,176 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-16 | S | D | 32,000 | $26.93 | 56,176 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.36 to $27.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2023-05-16 | S | D | 500 | $27.60 | 55,676 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.59 to $27.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Derivative | Stock Option (right to buy) | 2023-05-16 | M | D | 32,500 | $0.00 | 382,000 | D | $6.88 · — to 2031-01-25 | 32,500 Common Stock | (F5) 113,024 shares underlying this option vested on January 25, 2022, with the remaining shares vesting in monthly installments of 9,416 shares thereafter. |